SEC-FDA Bilateral MOU Signals Tighter Enforcement Coordination

On August 31, 2026, the SEC and FDA formalized a Memorandum of Understanding to strengthen cooperation, information-sharing, and enforcement—requiring heightened vigilance from FDA-regulated public companies.